<DOC>
	<DOCNO>NCT02031250</DOCNO>
	<brief_summary>This study aim improve locoregional control poor prognosis Head Neck Cancer ( HNC ) patient selectively escalate radiotherapy dose subvolumes tumor likely resistant standard Radiation Therapy ( RT ) use DCE-MRI ( Dynamic Contrast Enhanced Magnetic Resonance Imaging ) . Standard dos radiotherapy rest tissue surround normal tissue maintain .</brief_summary>
	<brief_title>Randomized Phase II Study DCE-MRI-based Dose Escalation Poor-prognosis Neck Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Patients must pathologically‐confirmed , previously untreated , non‐metastatic locally/regionally advanced squamous cell carcinoma head neck , stage III/IV , refer definitive chemo‐RT , meet one follow six criterion : 1 . Primary tumor and/or metastatic lymph node : unresectable , resection consider treat surgeon patient result unacceptable functional oncological result , patient refuse surgery , surgery possible due comorbidities . 2 . HPV ( ‐ ) ( Human Papillomavirus ) p16 ( ) locally/regionally advanced ( T3‐4 N2‐3 ) oropharyngeal cancer . 3 . HPV ( + ) p16 ( + ) locally/regionally advanced ( T4 N3 ) oropharyngeal cancer &gt; 10 pack year smoke history . 4 . T3 T4 laryngeal hypopharyngeal cancer locally advance , bulky ( &gt; 30 cc* ) , unresectable , patient decline surgery . 5 . Stage III/IV oral cavity paranasal sinus cancer patient refuse surgery unfit surgery . 6 . Locally/regionally advanced ( stage T3‐4 and/or N3 ) nasopharyngeal cancer EBV ( ‐ ) ( Epstein‐Barr Virus ) . KPS ( Karnofsky Performance Status : A measure general well activity daily live ; score range 0 100 100 represent perfect health ) &gt; 70 ( see Appendix A ) within two week enrollment . Pre‐treatment laboratory criterion within four week enrollment : WBC ( White Blood Cell ) &gt; 3500/ul , granulocyte &gt; 1500/ul . Platelet count &gt; 100,000/ul . Total Bilirubin &lt; 1.5 X ULN . AST ( Aspartate Aminotransferase ) ALT ( Alanine Aminotransferase ) &lt; 2.5 X ULN . Estimated Creatinine clearance &gt; 30cc/min . Patients must able receive protocol chemotherapy judgment treat Medical Oncologist . Patients adult ( Age &gt; 18 ) . All patient must inform investigational nature study give write informed consent accordance institutional federal guideline . EBV ( + ) Nasopharyngeal Carcinoma . Prior head neck radiation . Documented evidence distant metastasis . Patients active infection . Pregnant woman . Patients contraindication contrast enhanced MRI scan . These contraindication assess time enrollment use guideline set clinical use Institutional Standard Practice .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>